-- Dongfang Liu, Chief Medical Officer, on April 17, 2026, sold 50,000 shares in Nuvation Bio (NUVB) for $251,000. Following the Form 4 filing with the SEC, Liu has control over a total of 18,000 Class A common shares of the company, with 18,000 shares held directly.
SEC Filing: